India's Solara Active Pharma up after USFDA inspection ends

Alembic Pharmaceuticals

21/05/2024 08:43

** Shares of Solara Active Pharma Sciences  SOLA.NS  rise as
much as 3.9% before trimming some gains, last up 1.1% to 489.55
rupees 
    ** The active pharmaceutical ingredients (API) maker said
its Visakhapatnam facility completes U.S. FDA Inspection with
Zero 483 observations
    ** Including session's gains, stock up 47% YTD, while peers
Alembic Pharmaceuticals  ALEM.NS  and Laurus Labs  LAUL.NS  have
gained 26% and 3.7%, respectively


 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))